Resmed (RMD) Non-Current Deferred Tax Liability (2010 - 2026)

Resmed's Non-Current Deferred Tax Liability history runs 17 years deep, the most recent figure standing at $77.9 million for Q1 2026.

• Quarterly Non-Current Deferred Tax Liability fell 1.33% year-over-year to $77.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.9 million (down 1.33% YoY) and the FY2025 annual result came in at $77.7 million, down 2.09% from the prior year.
• Non-Current Deferred Tax Liability was $77.9 million for Q1 2026 at Resmed, roughly flat from $78.0 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $113.0 million in Q1 2023 and bottomed at $9.7 million in Q2 2022.
• A 5-year average of $72.8 million and a median of $79.0 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability jumped 955.13% — and 2024, when it retreated 23.4%.
• Resmed's Non-Current Deferred Tax Liability stood at $107.5 million in 2022, then retreated by 16.98% to $89.3 million in 2023, then retreated by 13.75% to $77.0 million in 2024, then advanced by 1.29% to $78.0 million in 2025, then declined by 0.08% to $77.9 million in 2026.
• Business Quant data shows RMD's Non-Current Deferred Tax Liability at $77.9 million in Q1 2026, $78.0 million in Q4 2025, and $77.6 million in Q3 2025.